showed that 67% (34/51) of the patients who were initially classified as GHQ "cases" became "noncases" after three months (p < 0-0001). There was no significant change from visit two to visit three.
Hospital Anxiety and Depression
There was a high level of acute anxiety amongst this population, with 60% (61/102) defined as "cases" before acyclovir was commenced. By the second visit this had almost halved to 35% (29/82), table 2. Using McNemar's test to assess any change in proportion from visit one to visit two, 43% (21/49) patients classified as anxiety "cases" before commencing treatment had become "noncases" within three months of commencing continuous acyclovir (p < 0.0001). Again, there was no change from visit two to visit three.
Acute depression was uncommon, with a negligibly small number of "cases" throughout the whole study: 14% (14/102) pretreatment, and 14% (7/50) post-treatment. 
Discussion
The study confirms that there is a substantial psychiatric morbidity in patients with frequently recurring genital herpes. At first visit, before treatment, many patients were greatly concerned about their infection and showed high levels of anxiety and depression. Yet within three months of commencing continuous acyclovir the percentage of GHQ cases had fallen from 63% to 26%. In this initial three month period substantial decreases were also found in illness concern; and hospital anxiety. Between subsequent visits there were no significant differences suggesting that any attitude change occurred within three months of commencing continuous acyclovir. One could surmise that the improvement in their wellbeing stems not from treatment, but from personal intervention and interest shown by the clinicians. However, many of the patients had been attending the clinic for a considerable period before attending the study, so that there was already a considerable patient/clinician relationship before treatment commenced. 
